Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,985.77 +1,639.61 (+2.51%) CMC Crypto 200
1,367.09 -6.75 (-0.49%)
Daré Bioscience, Inc. (DARE)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 43.73M |
| Enterprise value | 34.66M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 13.52 |
| Price/book (mrq) | 3.44 |
| Enterprise value/revenue | 12.34 |
| Enterprise value/EBITDA | -2.06 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.31 |
| 52-week change 3 | -51.98% |
| S&P500 52-week change 3 | 26.49% |
| 52-week high 3 | 1.0200 |
| 52-week low 3 | 0.2700 |
| 50-day moving average 3 | 0.4098 |
| 200-day moving average 3 | 0.4369 |
Share statistics
| Avg vol (3-month) 3 | 718.48k |
| Avg vol (10-day) 3 | 565.86k |
| Shares outstanding 5 | 100.58M |
| Implied shares outstanding 6 | 100.65M |
| Float 8 | 98.89M |
| % held by insiders 1 | 1.65% |
| % held by institutions 1 | 6.69% |
| Shares short (30 Apr 2024) 4 | 290.3k |
| Short ratio (30 Apr 2024) 4 | 0.3 |
| Short % of float (30 Apr 2024) 4 | 0.29% |
| Short % of shares outstanding (30 Apr 2024) 4 | 0.29% |
| Shares short (prior month 28 Mar 2024) 4 | 235.03k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 20 Jul 2017 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 20 Jul 2017 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -274.99% |
Management effectiveness
| Return on assets (ttm) | -59.02% |
| Return on equity (ttm) | -994.69% |
Income statement
| Revenue (ttm) | 2.81M |
| Revenue per share (ttm) | 0.03 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -30.7M |
| Net income avi to common (ttm) | -30.16M |
| Diluted EPS (ttm) | -0.3500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 10.48M |
| Total cash per share (mrq) | 0.1 |
| Total debt (mrq) | 1.4M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.86 |
| Book value per share (mrq) | -0.05 |
Cash flow statement
| Operating cash flow (ttm) | -38.86M |
| Levered free cash flow (ttm) | -27.18M |
© 2024 Yahoo. All rights reserved.